| 000 | 01614 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516103657.0 | ||
| 264 | 0 | _c20130212 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2012.07.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerighi, Stefania | |
| 245 | 0 | 0 |
_aHydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. _h[electronic resource] |
| 260 |
_bPharmacological research _cNov 2012 |
||
| 300 |
_a428-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xmetabolism |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aSulfides _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aGessi, Stefania | |
| 700 | 1 | _aVarani, Katia | |
| 700 | 1 | _aFazzi, Debora | |
| 700 | 1 | _aBorea, Pier Andrea | |
| 773 | 0 |
_tPharmacological research _gvol. 66 _gno. 5 _gp. 428-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2012.07.002 _zAvailable from publisher's website |
| 999 |
_c21982410 _d21982410 |
||